Fulcrum Equity Management Purchases Shares of 98,267 Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT)

Fulcrum Equity Management acquired a new stake in Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor acquired 98,267 shares of the company’s stock, valued at approximately $3,252,000. Innovator IBD Breakout Opportunities ETF accounts for approximately 1.3% of Fulcrum Equity Management’s investment portfolio, making the stock its 19th largest holding. Fulcrum Equity Management owned approximately 0.15% of Innovator IBD Breakout Opportunities ETF as of its most recent filing with the SEC.

Separately, Susquehanna International Group LLP bought a new stake in shares of Innovator IBD Breakout Opportunities ETF in the 4th quarter valued at approximately $320,000.

Shares of BOUT stock traded down $0.72 during trading hours on Thursday, hitting $33.06. The company had a trading volume of 12,738 shares, compared to its average volume of 24,270. Innovator IBD Breakout Opportunities ETF has a 12 month low of $18.77 and a 12 month high of $37.94. The firm’s fifty day moving average is $34.33 and its 200 day moving average is $30.42.

Featured Story: Understanding each part of a balance sheet

Want to see what other hedge funds are holding BOUT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT).

Institutional Ownership by Quarter for Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT)

Receive News & Ratings for Innovator IBD Breakout Opportunities ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD Breakout Opportunities ETF and related companies with MarketBeat.com's FREE daily email newsletter.